Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Escudier

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2008
The postchemotherapy PSA surge syndromeR Thuret, C Massard, M Gross-Goupil, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
Cancer Research|July 15, 1992
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasmsI Marcillac, F Troalen, J M Bidart, et al.
Medical Oncology (Northwood, London, England)|September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGETS Negrier, E Jäger, C Porta, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2008
[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?]Y Neuzillet, J-M Correas, B Escudier, et al.
Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinibR Thiam, L S Fournier, L Trinquart, et al.
Presse Medicale (Paris, France : 1983)|May 27, 1995
[Treatment of metastatic malignant insulinomas. 2 cases]L Mounedji-Boudiaf, P Rougier, S Culine, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2008
The postchemotherapy PSA surge syndromeR Thuret, C Massard, M Gross-Goupil, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1994
High-dose interleukin-2 two days a week for metastatic renal cell carcinoma: a FNCLCC multicenter studyB Escudier, A Ravaud, M Fabbro, et al.
Journal of the American College of Surgeons|October 1, 1995
Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectumD Elias, F Farace, F Triebel, et al.
Cancer Research|July 15, 1992
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasmsI Marcillac, F Troalen, J M Bidart, et al.
Medical Oncology (Northwood, London, England)|September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGETS Negrier, E Jäger, C Porta, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2008
[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?]Y Neuzillet, J-M Correas, B Escudier, et al.
Cancer Treatment Reviews|June 10, 2021
Checkpoint inhibitors in metastatic papillary renal cell carcinomaM de Vries-Brilland, D F McDermott, C Suárez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinibR Thiam, L S Fournier, L Trinquart, et al.
Presse Medicale (Paris, France : 1983)|May 27, 1995
[Treatment of metastatic malignant insulinomas. 2 cases]L Mounedji-Boudiaf, P Rougier, S Culine, et al.
Pageof 19